Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceHeart & metabolic

Tocotrienols

Tocotrienols are the less-studied half of the vitamin E family, extracted from palm or annatto. The preclinical biology is genuinely interesting, but human trials are small, short and heavily industry-linked — and the flagship cholesterol claim has not held up in meta-analysis.

What the science says

  • Lower cholesterol Limited evidence

    This is the original and most-repeated claim, based on small trials from the 1990s reporting 10–20% LDL reductions. A meta-analysis of the randomised evidence found no consistent, clinically meaningful improvement in total cholesterol or LDL across trials; results were heterogeneous and the early positive findings were not reproduced in better-controlled work. Doses of 200–400 mg/day for 8–24 weeks are the typical exposure tested.

  • Improve bone health in postmenopausal women Limited evidence

    Small trials of annatto tocotrienol (typically 300–600 mg/day for 12 weeks) report shifts in bone turnover markers such as CTX and BSAP. No trial has measured bone mineral density change over a meaningful period or fracture incidence, which are the outcomes that matter. This is early-stage evidence being marketed as a conclusion.

  • Broad antioxidant and metabolic benefits Limited evidence

    A systematic review of RCTs of palm tocotrienol-rich fraction found scattered signals on oxidative stress markers and some subgroup effects, but concluded the trial base is small, heterogeneous and insufficient to support clinical recommendations. Claims around fatty liver, neuroprotection and cancer rest almost entirely on cell and animal work.

  • Better than regular vitamin E Limited evidence

    Tocotrienols do have distinct properties — faster membrane distribution, HMG-CoA reductase degradation in vitro — but 'different' is not 'better' until outcomes say so. Practically, high tocotrienol intake can lower alpha-tocopherol status, and alpha-tocopherol in mixed products competes for the alpha-tocopherol transfer protein and blunts tocotrienol absorption. Products combining both may work against themselves.

Dosage & safety

Studied doseTrials commonly use 200–400 mg/day of tocotrienol-rich fraction (delta- and gamma-heavy from annatto, or mixed from palm), taken with a fat-containing meal, for 8–24 weeks. Some bone trials went to 600 mg/day. There is no established requirement — tocotrienols are not essential nutrients; alpha-tocopherol is the form that meets vitamin E requirements.
SafetyGenerally well tolerated up to about 400 mg/day in trials, with mild GI complaints the main report. As vitamin E family compounds, high doses carry a theoretical bleeding risk alongside warfarin, DOACs and antiplatelet drugs; stop before elective surgery. Separately, the large trials linking high-dose vitamin E to increased all-cause mortality and to prostate cancer risk (SELECT) used alpha-tocopherol, not tocotrienols — but many products blend them, so read the label. May interact with statins (shared HMG-CoA pathway) and with chemotherapy regimens where antioxidant supplementation is discouraged. Safety in pregnancy and lactation is not established. Not banned in sport.

Scientific references

Where to buy

Swanson Vitamins, Tocotrienols From Annatto, 50 mg, 60 Softgels

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic